{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:35:31Z","timestamp":1793352931200,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Opioid use disorder (OUD) among US adolescents represents a public health crisis, with overdose deaths becoming a leading cause of mortality. Despite their efficacy, naloxone and buprenorphine remain underutilized. The pediatric emergency department (PED) presents an intervention opportunity, as many adolescents with OUD present there before fatal overdoses. This quality improvement initiative examined the use of education and hybrid screening to improve the provision of naloxone and buprenorphine in the PED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A multifaceted OUD screening and treatment protocol was implemented in a PED using Best Practice Alerts (BPA) triggered by specific chief complaints (CC), alerting providers to the need for additional screening. Components included provider education, formulary changes, and clinical pathways. Data from adolescent encounters over 45 months were analyzed, comparing naloxone and buprenorphine prescribing rates before and after implementation. Secondary analyses examined demographics, insurance, and psychiatric comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>During the study, 63 adolescents initiated buprenorphine, and 246 received naloxone. Among patients with BPA-qualifying CCs, naloxone dispensing increased from 3.89% to 11.39% and buprenorphine prescribing increased from 1.04% to 2.46%. Postimplementation, Black\/African American adolescents and those with government insurance received more medications than peers, and overall naloxone prescribing increased from 0.4% to 0.79% of all visits. Patients triggering the BPA experienced longer ED stays regardless of medication receipt, with no increase in return visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Electronic screening alerts coupled with provider education increased the provision of medications for adolescents at risk for opioid-related harm. The intervention is achievable in a PED without increasing return visits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pec.0000000000003640","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:00:38Z","timestamp":1781593238000},"page":"814-822","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Improving Naloxone and Buprenorphine Provision in the Pediatric Emergency Department Through Education and Chief Complaint-Triggered Screening"],"prefix":"10.1097","volume":"42","author":[{"given":"Chris","family":"Buresh","sequence":"first","affiliation":[{"name":"Division of Emergency Medicine, Seattle Children\u2019s Hospital"},{"name":"Department of Emergency Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Seattle Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lowry","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Seattle Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sandelich","sequence":"additional","affiliation":[{"name":"Departments of Emergency Medicine and Pediatrics, Penn State, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Rutman","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Seattle Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1056\/NEJMc2201761","article-title":"Current causes of death in children and adolescents in the United States","volume":"386","author":"Goldstick","year":"2022","journal-title":"N Engl J Med"},{"issue":"suppl","key":"R3-20261030","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"e0256752","DOI":"10.1371\/journal.pone.0256752","article-title":"Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: a placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients","volume":"17","author":"Moss","year":"2022","journal-title":"PLoS One"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bja\/ael051","article-title":"Buprenorphine induces ceiling in respiratory depression but not in analgesia","volume":"96","author":"Dahan","year":"2006","journal-title":"Br J Anaesth"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"Brit Med J"},{"issue":"suppl 2","key":"R7-20261030","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1542\/peds.2020-023523D","article-title":"Evidence-based treatment of young adults with substance use disorders","volume":"147","author":"Hadland","year":"2021","journal-title":"Pediatrics"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"e195183","DOI":"10.1001\/jamapediatrics.2019.5183","article-title":"Receipt of addiction treatment after opioid overdose among medicaid-enrolled adolescents and young adults","volume":"174","author":"Alinsky","year":"2020","journal-title":"JAMA Pediatr"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"e2022058755","DOI":"10.1542\/peds.2022-058755","article-title":"Buprenorphine dispensing among youth aged \u226419 years in the United States: 2015-2020","volume":"151","author":"Terranella","year":"2023","journal-title":"Pediatrics"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"111136","DOI":"10.1016\/j.drugalcdep.2024.111136","article-title":"Analysis of rising cases of adolescent opioid use presentations to the emergency department and their management","volume":"258","author":"Sidlak","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jadohealth.2024.02.024","article-title":"Characteristics of opioid toxicity deaths among adolescents and young adults in Ontario prior to and during the COVID-19 Pandemic","volume":"75","author":"Akbar","year":"2024","journal-title":"J Adolesc Health"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"e1330","DOI":"10.1542\/peds.2011-1754","article-title":"Substance use screening, brief intervention, and referral to treatment for pediatricians","volume":"128","author":"Levy","year":"2011","journal-title":"Pediatrics"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jadohealth.2023.02.010","article-title":"Implementing evidence-based, electronic, substance-use screening in a primary care clinic","volume":"73","author":"Ebersole","year":"2023","journal-title":"J Adolesc Health"},{"key":"R14-20261030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.annemergmed.2023.03.033","article-title":"Impact of universal screening and automated clinical decision support for the treatment of opioid use disorder in emergency departments: a difference-in-differences analysis","volume":"82","author":"Lowenstein","year":"2023","journal-title":"Ann Emerg Med"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"e2020020610","DOI":"10.1542\/peds.2020-020610","article-title":"Adolescent risk behavior screening and interventions in hospital settings: a scoping review","volume":"147","author":"Pfaff","year":"2021","journal-title":"Pediatrics"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.amepre.2024.12.020","article-title":"Widening racial disparities in the US overdose epidemic","volume":"68","author":"Smith","year":"2025","journal-title":"Am J Prev Med"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"282","DOI":"10.15585\/mmwr.mm7416a2","article-title":"Trends in suspected fentanyl-involved nonfatal overdose emergency department visits, by age group, sex, and race and ethnicity\u2014United States, October 2020\u2013March 2024","volume":"74","author":"Pickens","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1001\/jama.2019.21381","article-title":"Screening for unhealthy drug use: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"323","author":"Patnode","year":"2020","journal-title":"JAMA"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"e20183415","DOI":"10.1542\/peds.2018-3415","article-title":"Predictive validity of the CRAFFT for substance use disorder","volume":"144","author":"Shenoi","year":"2019","journal-title":"Pediatrics"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"R24-20261030","doi-asserted-by":"crossref","first-page":"e035376","DOI":"10.1136\/bmjopen-2019-035376","article-title":"Place, poverty and prescriptions: a cross-sectional study using Area Deprivation Index to assess opioid use and drug-poisoning mortality in the USA from 2012 to 2017","volume":"10","author":"Kurani","year":"2020","journal-title":"BMJ Open"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics\u201425 states and the District of Columbia, 2019\u20132020","volume":"71","author":"Kariisa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jadohealth.2025.02.015","article-title":"Trends in emergency department visits for nonfatal opioid overdoses among adolescents","volume":"76","author":"Toce","year":"2025","journal-title":"J Adolesc Health"},{"key":"R28-20261030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMp2312084","article-title":"The overdose crisis among US adolescents","volume":"390","author":"Friedman","year":"2024","journal-title":"N Engl J Med"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"e2514997","DOI":"10.1001\/jamanetworkopen.2025.14997","article-title":"Decline in US drug overdose deaths by region, substance, and demographics","volume":"8","author":"Post","year":"2025","journal-title":"JAMA Netw Open"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.15288\/jsad.2019.80.393","article-title":"Medications for maintenance treatment of opioid use disorder in adolescents: a narrative review and assessment of clinical benefits and potential risks","volume":"80","author":"Camenga","year":"2019","journal-title":"J Stud Alcohol Drugs"},{"key":"R31-20261030","doi-asserted-by":"crossref","first-page":"e2435416","DOI":"10.1001\/jamanetworkopen.2024.35416","article-title":"Clinician willingness to prescribe medications for opioid use disorder to adolescents in Indiana","volume":"7","author":"Aalsma","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"e2024066226","DOI":"10.1542\/peds.2024-066226","article-title":"Initiation of buprenorphine treatment of opioid use disorder in pediatric emergency departments","volume":"154","author":"Kumar","year":"2024","journal-title":"Pediatrics"},{"key":"R33-20261030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/add.16394","article-title":"Performance of International Classification of Disease-10 codes in detecting emergency department patients with opioid misuse","volume":"119","author":"Chhabra","year":"2024","journal-title":"Addiction"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PEC.0000000000003640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:01:18Z","timestamp":1793350878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PEC.0000000000003640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000003640","relation":{},"ISSN":["0749-5161","1535-1815"],"issn-type":[{"value":"0749-5161","type":"print"},{"value":"1535-1815","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"2025-12-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}